FdaApplication

ANDA 203161

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeANDA
approval_date2012-09-27

Products (3)

ProductActive ingredientStrengthDosage form
IRBESARTANIRBESARTAN300MGTABLET;ORAL
IRBESARTANIRBESARTAN75MGTABLET;ORAL
IRBESARTANIRBESARTAN150MGTABLET;ORAL

3 products